Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
nyse-pbyi
Press Release
Jul 23, 2014
Puma Biotechnology (PBYI) Wins a Battle on the Breast-Cancer War
Puma Biotechnology (PBYI) reported top line results from the Phase III clinical trial of the company's investigational drug PB272 (neratinib) for the extended adjuvant treatment of breast cancer
Read More
First
Prev
1
Next
Last